Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Alonso

Showing results (341-350 of 349) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 349 results.
Leukemia Research|July 12, 2025
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndromeJames M Foran, Guillermo F Sanz, Justin M Watts, et al.
Crohn'S & Colitis 360|January 21, 2025
Dysplasia and Colorectal Cancer Surveillance in Ulcerative Colitis Patients in Latin America: Real-World DataViviana Parra-Izquierdo, William Otero-Regino, Fabian Juliao-Baños, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Cancers|January 21, 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz, et al.
Leukemia|July 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemiaGonzalo Carreño-Tarragona, Rodrigo Gil-Manso, Juan Carlos Hernández-Boluda, et al.
Nefrologia|December 12, 2022
Recommendations for living donor kidney transplantationMiguel Ángel Frutos, Marta Crespo, María de la Oliva Valentín, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Haematologica|July 16, 2026
Co-mutation signatures are age-dependent and impact the prognosis in <i>NPM1</i>-mutated acute myeloid leukemia: a PETHEMA multicenter studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
Blood|June 8, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
Pageof 35

Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Leukemia Research|July 12, 2025
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndromeJames M Foran, Guillermo F Sanz, Justin M Watts, et al.
Crohn'S & Colitis 360|January 21, 2025
Dysplasia and Colorectal Cancer Surveillance in Ulcerative Colitis Patients in Latin America: Real-World DataViviana Parra-Izquierdo, William Otero-Regino, Fabian Juliao-Baños, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Cancers|January 21, 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz, et al.
Leukemia|July 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemiaGonzalo Carreño-Tarragona, Rodrigo Gil-Manso, Juan Carlos Hernández-Boluda, et al.
Nefrologia|December 12, 2022
Recommendations for living donor kidney transplantationMiguel Ángel Frutos, Marta Crespo, María de la Oliva Valentín, et al.
Cancers|February 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase InhibitorsLucía Pérez-Lamas, Alejandro Luna, Concepción Boque, et al.
Haematologica|July 16, 2026
Co-mutation signatures are age-dependent and impact the prognosis in <i>NPM1</i>-mutated acute myeloid leukemia: a PETHEMA multicenter studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
Blood|June 8, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA studyJosé Vicente Gil, Claudia Sargas, Rosa Ayala, et al.
Pageof 35